Clinical Trial Update: The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota

View source ↗

Summary

A clinical trial from Fudan University is evaluating whether adding a PD-1 monoclonal antibody to chemotherapy improves outcomes in metastatic gastric cancer, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Chemotherapy (combination regimen) (Cytotoxic chemotherapy)
• PD-1 monoclonal antibody

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer, Gut Microbiota | Status: RECRUITING